Price Prediction
Salesforce (CRM) Stock Price Prediction: Oversold rebound attempt meets a broken trend
Salesforce (CRM) was hit hard on November 17, 2026, with the stock closing at $194.52 and the current price marked at $195.14. The technical tape is deeply oversold, but the broader trend remains w...
Price action: a sharp selloff into support
Salesforce (CRM) is trading at $195.14, after a 24-hour drop of 8.54% from a high-low range of $213.80 to $193.60. That leaves CRM just above the lower edge of the recent range and below its $200.85 pivot point, which matters because price is now sitting in the zone where short-covering often competes with further de-risking.
The selloff also follows a weak close on November 17, 2026, when CRM finished at $194.52, down 9.45% on the session, before edging to $195.72 after hours. Investing.com attributed that drop to renewed doubts around AI monetization, caution in enterprise spending, and a technical breakdown.
Technical damage is real, but momentum is stretched
The moving-average stack is still bearish: SMA 7 at $210.73, SMA 20 at $217.07, and SMA 50 at $229.01, with the stock trading below all three. EMA 12 at $211.73 and EMA 26 at $219.34 reinforce that CRM remains below trend.
At the same time, momentum is washed out. The 14-day RSI is 22.78, which is oversold territory, while the stochastic readings are pinned near the floor at %K 4.30 and %D 3.44. MACD remains negative at -7.6062. That combination usually says the decline is extended, but it does not by itself prove a reversal.
Bollinger positioning points to the same tension. The lower band is $199.18, and CRM is still trading below it, with a %B of -0.1129. That means the stock is not merely weak; it is stretched beneath the lower volatility envelope. The daily ATR of $6.52 also implies wide swings can continue.
Levels that matter from here
The immediate structure is clear:
- Immediate support: $187.89
- Strong support: $180.65
- Pivot point: $200.85
- Immediate resistance: $208.09
- Strong resistance: $221.05
Below $187.89, the chart leaves little room before the next support at $180.65. On the upside, a move back through $200.85 would be the first sign that the oversold bounce is trying to develop into something more durable. Above that, $208.09 is the near-term hurdle that would need to give way before the stock can challenge the stronger resistance band.
Derivatives are not confirming outright panic
Binance Futures data shows funding flat at 0.0000%, which is neutral rather than strongly one-sided. Open interest stands at 3,738.02 contracts, with daily open interest value at $798,291 and a 24-hour OI change of 10.64%. That says positioning is building, but the neutral funding rate means the market is not showing a clear, crowded directional bias.
The long/short ratios lean constructive but not emphatic. Binance global accounts show 57.2% long versus 42.8% short, while top-trader accounts show 56.5% long versus 43.5% short. Taker flow is more forceful on the buy side, with a 1.7121 taker buy/sell ratio. Taken together, that suggests dip-buying interest is present, but it has not yet reversed the broader price damage.
Fundamentals and analyst backdrop
On the analyst side, the tone remains supportive despite the selloff. stockanalysis.com cites 56 analysts with a consensus Buy rating and an average price target of $287.08, while MarketBeat reported a Moderate Buy consensus from 51 analysts with an average target of $278.98. Stifel reiterated a Buy rating and a $300 target on November 16, 2026, pointing to expected strength in current remaining performance obligation and subscription revenue, along with an ongoing shift toward premium products.
That does not erase the chart damage, but it does frame the setup: the market is pressing CRM lower even as published analyst targets remain materially above the current share price.
What would change the setup
If CRM can reclaim $200.85 and then clear $208.09, the current selloff starts to look like a deep oversold reset rather than a fresh downtrend leg. If it fails to hold $187.89, the next test is $180.65, and a break there would keep pressure on the shares even with momentum already stretched.
The key uncertainty is timing: the available evidence shows price stress, oversold conditions, and higher positioning, but it does not provide a dated operational catalyst that would force a near-term resolution.